9072 Federal Register / Vol. 87, No. 33 / Thursday, February 17, 2022 / Notices 

notwithstanding the inclusion of the 

routine notice. 

Elizabeth A. Fowler, 

Acting Deputy Director, Indian Health 

Service. 

[FR Doc. 2022–03390 Filed 2–16–22; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Science 

Advisory Board for Biosecurity. 

The meeting will be held as a virtual 

meeting and is open to the public as 

indicated below. Individuals who plan 

to view the virtual meeting and need 

special assistance or other reasonable 

accommodations to view the meeting 

should notify the Contact Person listed 

below in advance of the meeting. The 

meeting will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting website (http://

videocast.nih.gov/). 

Name of Committee: National Science 

Advisory Board for Biosecurity. 

Date: February 28, 2022. 

Time: 12:00 p.m. to 1:00 p.m. 

Agenda: The National Science Advisory 

Board for Biosecurity meeting will include a 

review of the charge to the committee and 

discussion of next steps for the committee. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Suite 750, Bethesda, MD 

20892 (Virtual Meeting Link is available at 

https://osp.od.nih.gov/biotechnology/ 

national-science-advisory-board-forbiosecurity-nsabb/#meetings). 

Contact Person: Cari Young, Office of 

Science Policy, National Institutes of Health, 

6705 Rockledge Drive, Suite 750, Bethesda, 

MD 20892, 301–496–9838, SciencePolicy@

od.nih.gov. 

Any interested person may file written 

comments by forwarding the statement to the 

Contact Person listed on this notice at least 

two days prior to the meeting date. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

Information is also available on the NIH 

Office of Science Policy’s web page: https:// 

osp.od.nih.gov/biotechnology/nationalscience-advisory-board-for-biosecuritynsabb/, where an agenda, link to the webcast 

meeting, and any additional information for 

the meeting will be posted when available. 

This notice is being published less than 15 

days prior to the meeting due to scheduling 

difficulties. 

Dated: February 14, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03406 Filed 2–16–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR19–294: 

Early-Stage Preclinical Validation of 

Therapeutic Leads for Diseases of Interest to 

the NIDDK. 

Date: March 15, 2022. 

Time: 10:00 a.m. to 9:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Latha Meenalochana 

Malaiyandi, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 812Q, Bethesda, MD 20892, (301) 435– 

1999, malaiyandilm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Endocrinology, Metabolism, 

Nutrition and Reproductive Sciences. 

Date: March 15, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Jonathan Michael 

Peterson, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 867–5309, 

jonathan.peterson@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR20–117: 

Maximizing Investigators Research Award 

(MIRA) for Early Stage Investigators (R35— 

Clinical Trial Optional). 

Date: March 16–17, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Zubaida Rangwalla 

Saifudeen, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20817, 301.827.3029, 

zubaida.saifudeen@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Topics in Metabolism and 

Reproductive Sciences. 

Date: March 16, 2022. 

Time: 12:00 p.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Hui Chen, MD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 6164, Bethesda, MD 20892, 301– 

435–1044, chenhui@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; High 

Throughput Screening. 

Date: March 23, 2022. 

Time: 9:30 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sulagna Banerjee, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 612.309.2479, sulagna.banerjee@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–OD– 

20–005: Transformative Research Award for 

the INCLUDE Project (R01). 

Date: March 24, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Katherine M. Malinda, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4140, 

MSC 7814, Bethesda, MD 20892, 301–435– 

0912, katherine.malinda@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Special 

Topics: Biomaterials, Biointerfaces, 

Instrumentation, and Systems Development. 

Date: March 25, 2022. 

Time: 9:00 a.m. to 7:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Zarana Patel, Scientific 

Review Officer, The Center for Scientific 


lotter on DSK11XQN23PROD with NOTICES1